Collaborative effort
Collaborative effort to conduct a study aimed at improving the diagnosis of Alzheimer’s and related dementias for everyone
October 28, 2024 10:00 ET | Global Alzheimer’s Platform Foundation®
Washington D.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome the initial strategic partners in the Bio-Hermes-002 study. These...
sns insider pvt ltd.png
Companion Diagnostics Market Size Worth US$ 21.15 billion by 2032, Rising Prevalence of Cancer and Advances in Precision Medicine Drives Growth | Research by SNS Insider
October 09, 2024 09:00 ET | SNS Insider pvt ltd
Pune, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Companion Diagnostics Market Size Analysis: “According to SNS Insider Research, The Companion Diagnostics Market Size was valued at USD 7.66 Billion in 2023,...
Compass-logo-RGB-outlines.png
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
October 04, 2024 10:31 ET | Compass Therapeutics
BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
GMILogo_Vertical-Gradient.png
Immune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market Insights Inc.
October 01, 2024 05:30 ET | Global Market Insights Inc.
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Immune Checkpoint Inhibitors Market size reached USD 47.4 billion in 2023 and is projected to register a CAGR of 16.7% from 2024 to 2032...
DMR Logo.png
Proteomics Market Size To Reach USD 92.8 Billion By 2033, At 14.7% CAGR: Insights by Dimension Market Research
September 10, 2024 11:09 ET | Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global Proteomics Market size is expected to reach USD 27.0 billion by 2024 and it is further anticipated to reach a market value of USD...
DMR Logo.png
Precision Medicine Market Is Expected To Reach Revenue Of USD 225.7 Bn By 2033, At 11.6% CAGR: Dimension Market Research
September 10, 2024 11:03 ET | Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global Precision Medicine Market is to reach USD 83.9 billion by 2024 and is further anticipated to reach USD 225.7 billion by 2033...
Biognosys_Logo_Color.png
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
August 29, 2024 08:27 ET | Biognosys AG
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
Dementia Mission Com
Dementia Mission Competition Selects Four Companies For Innovative Alzheimer’s Biomarker Study
July 10, 2024 09:05 ET | Global Alzheimer’s Platform Foundation®
Washington D.C., July 10, 2024 (GLOBE NEWSWIRE) -- With groundbreaking creativity and breathtaking speed, this phase 3 competition, funded by Innovate UK, the UK’s innovation agency, is supporting...
DMR Logo.png
Personalized Medicine Biomarker Market Size to Reach USD 72.7 Billion By 2033, at 17.5 CAGR: Insights by Dimension Market Research
July 01, 2024 11:34 ET | Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Personalized Medicine Biomarker Market size is expected to reach USD 17.0 billion by 2024 and it is further anticipated to reach...
Biognosys Newton, Massachusetts proteomics facility
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET | Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics